Evidence map›Paper›PMID 34356585›Full record

ArticleChildren (Basel, Switzerland)2021

Transnasal Sphenopalatine Ganglion Block for the Preventive Treatment of Chronic Daily Headache in Adolescents.

Megan Kouri, Marta Somaini, Victor Hugo González Cárdenas, Kacper Niburski, Marie Vigouroux, Pablo Ingelmo

Registry-linked trialOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Children (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05213065 (Efficacy of Transnasal Sphenopalatine Ganglion Block Using TX360® Device for Children and Adolescents With Chronic Daily Headaches), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05213065 naunknown statusnot on this mapstarted 2022, after this paper: background citation

Efficacy of Transnasal Sphenopalatine Ganglion Block Using TX360® Device for Children and Adolescents With Chronic Daily Headaches: A Single Center, Prospective, Randomized, Double Blind, Placebo-controlled Study Assessing the Efficacy of the Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Daily Headache in Children and Adolescents

TypeinterventionalSponsorPablo IngelmoRan2022 to 2024Enrolled120ConditionsChronic Daily Headache, Post-Traumatic HeadacheArmsSphenopalatine ganglion block with 0.5% bupivacaine, Sphenopalatine ganglion block with saline
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Megan KouriFaculty of Medicine, McGill University, Montreal, QC H3G 2M1, Canada.
Marta SomainiDepartment of Anaesthesia, Grande Ospedale Metropolitano Niguarda, 201262 Milano, Italy.
Victor Hugo González CárdenasFaculty of Medicine, Fundación Universitaria de Ciencias de la Salud (FUCS), 111221 Bogotá, Colombia.ORCID 0000-0003-2193-1106
Kacper NiburskiFaculty of Medicine, McGill University, Montreal, QC H3G 2M1, Canada.
Marie VigourouxFaculty of Dentistry, McGill University, Montreal, QC H3A 1G1, Canada.
Pablo IngelmoEdwards Family Interdisciplinary Center for Complex Pain, Montreal Children's Hospital, McGill University Health Center, Montreal, QC H4A 3J1, Canada.
McGill University · CAMontreal Children's Hospital · CAAzienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda · ITHospital Universitario de la Samaritana · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic headaches are a major source of morbidity in the pediatric population, affecting physical function, school attendance, social capacity, mood, and sleep. In adults, repetitive sphenopalatine ganglion (SPG) blockade has been studied as a preventive treatment for chronic migraines. This case series aims to evaluate the SPG block for the preventive treatment of chronic daily headache (CDH) in adolescents. We prospectively evaluated 17 adolescents (14 females, 14 ± 1 year) with CDH not responding to cognitive behavioral therapy (CBT), physiotherapy, and standard medications. Each patient received 10 SPG blocks (two blocks/week) using the Tx360

Indexed as

adolescentschronic headachechronic painmigrainesphenopalatine ganglionTx360®

Identifiers

PMID34356585
PMCPMC8306937
OpenAlexW3186577365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.